A comprehensive review of the PARTNER trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 3 SUPPL., 2013, Pages

  Svensson, Lars G ^a   Tuzcu, Murat ^a   Kapadia, Samir ^a   Blackstone, Eugene H ^a   Roselli, Eric E ^a   Gillinov, A Marc ^a   Sabik III, Joseph F ^a   Lytle, Bruce W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; BLEEDING; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCARDITIS; FEMORAL ARTERY; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMORAL ARTERY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL COSTS; HUMANS; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873620733     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.11.051     Document Type: Conference Paper

References (24)

1. S.K. Kodali, M.R. Williams, C.R. Smith, L.G. Svensson, J.G. Webb, and R.R. Makkar Two-year outcomes after transcatheter or surgical aortic-valve replacement: the PARTNER trial investigators N Engl J Med 2012 March 26 [Epub ahead of print]
2. R.R. Makkar, G.P. Fontana, H. Jilaihawi, S. Kapadia, A.D. Pichard, and P.S. Douglas Transcatheter aortic-valve replacement for inoperable severe aortic stenosis: the PARTNER trial investigators N Engl J Med 2012 March 26 [Epub ahead of print]
3. D.C. Miller, E.H. Blackstone, M.J. Mack, L.G. Svensson, S.K. Kodali, and S. Kapadia Transcatheter (TAVR) vs surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial: the PARTNER trial investigators and patients: the PARTNER Stroke Substudy Writing Group and Executive Committee J Thorac Cardiovasc Surg 143 2012 832 843.e13
4. M.R. Reynolds, E.A. Magnuson, Y. Lei, M.B. Leon, C.R. Smith, and L.G. Svensson Placement of aortic transcatheter valves (PARTNER) investigators: health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis Circulation 124 2011 1964 1972
5. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter vs surgical aortic-valve replacement in high-risk patients: the PARTNER trial investigators N Engl J Med 364 2011 2187 2198
6. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery: the PARTNER trial investigators N Engl J Med 363 2010 1597 1607
7. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1988 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
8. S.M. O'Brien, D.M. Shahian, G. Filardo, V.A. Ferraris, C.K. Haan, and J.B. Rich The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2: isolated valve surgery Ann Thorac Surg 88 2009 S23 S42
9. B. Lung, A. Cachier, G. Baron, D. Messika-Zeitoun, F. Delahaye, and P. Tornos Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
10. T.M. Dewey, D. Brown, W.H. Ryan, M.A. Herbert, S.L. Prince, and M.J. Mack Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement J Thorac Cardiovasc Surg 135 2008 180 187
11. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
12. A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, and L. Sebagh Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis J Am Coll Cardiol 43 2004 698 703
13. A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, and D. Nercolini Treatment of calcific aortic stenosis with the percutaneous heart valve: midterm follow-up from the initial feasibility studies: the French experience J Am Coll Cardiol 47 2006 1214 1223
14. J.G. Webb, M. Chandavimol, C.R. Thompson, D.R. Ricci, R.G. Carere, and B.I. Munt Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
15. T. Walther, P. Simon, T. Dewey, G. Wimmer-Greinecker, V. Falk, and M.T. Kasimir Transapical minimally invasive aortic valve implantation: multicenter experience Circulation 116 2007 I-240 I-245
16. L.G. Svensson, T. Dewey, S. Kapadia, E.E. Roselli, A. Stewart, and M. Williams United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex Ann Thorac Surg 86 2008 46 55
17. N. Piazza, E. Grube, U. Gerckens, P. den Heijer, A. Linke, and O. Luha Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval Eurointervention 4 2008 242 249
18. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefèvre, and H. Treede Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry Circulation 122 2010 62 69
19. C.W. Akins, D.C. Miller, M.I. Turina, N.T. Kouchoukos, E.H. Blackstone, and G.L. Grunkemeier Guidelines for reporting mortality and morbidity after cardiac valve interventions J Thorac Cardiovasc Surg 135 2008 732 738
20. D.M. Finkelstein, and D.A. Schoenfeld Combining mortality and longitudinal measures in clinical trials Stat Med 18 1999 1341 1354
21. M.R. Reynolds, E.A. Magnuson, K. Wang, Y. Lei, K. Vilain, and J. Walczak Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort B): PARTNER investigators Circulation 125 2012 1102 1109
22. L.G. Svensson Percutaneous aortic valves: effective in inoperable patients, what price in high-risk patients? J Thorac Cardiovasc Surg 140 2010 S10 S13
23. H.V. Schaff Transcatheter aortic-valve implantation: at what price? N Engl J Med 364 2011 2256 2258
24. Center for Medicare and Medicaid Services. Available at: http://www.cms.gov.